These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3531904)

  • 1. Perinatal toxicology and the law.
    Morris RA; Sonderegger TB
    Neurobehav Toxicol Teratol; 1986; 8(4):363-7. PubMed ID: 3531904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal applications and implications for neurotoxin research of the developing organism.
    Morris RA; Sonderegger TB
    Neurobehav Toxicol Teratol; 1984; 6(4):303-6. PubMed ID: 6514090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal implications for research in the developing organism.
    Morris RA
    Neurotoxicology; 1986; 7(2):3-17. PubMed ID: 3785755
    [No Abstract]   [Full Text] [Related]  

  • 4. Perinatal substance abuse and human subjects research: are privacy protections adequate?
    Marshall MF; Menikoff J; Paltrow LM
    Ment Retard Dev Disabil Res Rev; 2003; 9(1):54-9. PubMed ID: 12587139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the perinatal narcotic addiction conference and future research goals in developmental pharmacology of abused drugs.
    Harbison RD; Braude MC
    Addict Dis; 1975; 2(1-2):1-5. PubMed ID: 1163355
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal and fetal effects from substance use.
    Rayburn WF
    Clin Perinatol; 2007 Dec; 34(4):559-71, vi. PubMed ID: 18063105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse.
    Ludlow JP; Evans SF; Hulse G
    Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):302-6. PubMed ID: 15282000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit drug use by pregnant women.
    American Public Health Association
    Am J Public Health; 1991 Feb; 81(2):253-4. PubMed ID: 11642867
    [No Abstract]   [Full Text] [Related]  

  • 9. Influencing physician response to prenatal substance exposure through state legislation and work-place policies.
    Zellman GL; Jacobson PD; Bell RM
    Addiction; 1997 Sep; 92(9):1123-31. PubMed ID: 9374009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State actions to control fetal abuse: ramifications for child welfare practice.
    Madden RG
    Child Welfare; 1993; 72(2):129-40. PubMed ID: 8444065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
    Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
    Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological principles in pregnancy].
    Villanueva LA; Valenzuela F
    Gac Med Mex; 1998; 134(5):575-82. PubMed ID: 9842139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-based interventions for improving perinatal and neonatal health outcomes in developing countries: a review of the evidence.
    Bhutta ZA; Darmstadt GL; Hasan BS; Haws RA
    Pediatrics; 2005 Feb; 115(2 Suppl):519-617. PubMed ID: 15866863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unwanted pregnancy--medical and ethical dimensions.
    Ravindran J
    Med J Malaysia; 2003 Mar; 58 Suppl A():23-35. PubMed ID: 14556348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental origins of environmentally induced disease and dysfunction International Conference on Foetal Programming and Developmental Toxicity, Tórshavn, Faroe Islands, 20-24 May, 2007.
    Grandjean P; Weihe P
    Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):71-2. PubMed ID: 18226056
    [No Abstract]   [Full Text] [Related]  

  • 17. National Institute on Drug Abuse Conference report on placental proteins, drug transport, and fetal development.
    Thadani PV; Strauss JF; Dey SK; Anderson VM; Audus KL; Coats KS; Cross JC; Erlebacher A; Ganapathy V; Linzer DI; Miller RK; Novak DA; Rapaka RS; Sadovsky Y; Salafia CM; Soares M; Unadkat J
    Am J Obstet Gynecol; 2004 Dec; 191(6):1858-62. PubMed ID: 15592265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal alcohol spectrum disorders: when science, medicine, public policy, and laws collide.
    Warren KR; Hewitt BG
    Dev Disabil Res Rev; 2009; 15(3):170-5. PubMed ID: 19731390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research outcomes of prenatal substance exposure and the need to review policies and procedures regarding child abuse reporting.
    Barth RP
    Child Welfare; 2001; 80(2):275-96. PubMed ID: 11291905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.